WATSON 3330 (Cyclobenzaprine hydrochloride 7.5 mg)
Pill imprint WATSON 3330 has been identified as Cyclobenzaprine hydrochloride 7.5 mg.
Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; fibromyalgia; chronic myofascial pain; migraine (and more), and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy. Cyclobenzaprine 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 3330
- Strength:
- 7.5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Victory Pharma
- National Drug Code (NDC):
- 68453-0950
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
calcium phosphate dibasic anhydrous
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
magnesium stearate
microcrystalline cellulose
titanium dioxide
More about cyclobenzaprine
Consumer resources
- Other brands: Flexeril, Amrix, Comfort Pac with Cyclobenzaprine, Fexmid
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
